JYNT on Nasdaq
JOINT Corp
American patent owners and lessors company, incorporated in Delaware.
Price unavailable
Last updated Oct 18, 2026.
Overview
Compare with Acacia Research, Digital Turbine or Royalty Management Holding Corp, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
-1.7%Operating margin3
5.3%Net margin3
5.2%Revenue growth, 20253
19.3%Return on equity3
$334.7KFree cash flow3
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Royalty brought in 60% of the revenue JOINT Corp broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Royalty | $32.1M | $33.2M |
| Advertising | $9.2M | $10.5M |
| Technology Service | $5.7M | $6.0M |
| Franchise | $3.0M | $3.4M |
| Product and Service, Other | $2.2M | $1.8M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue19¢$11.2M
- Selling, general and admin76¢$44.6M
- Income tax0¢$38.7K
- Profit5¢$2.9M
Out of $54.9M in revenue.3
Where each dollar of operating cash went, fiscal 2025
- Capital spending12¢$1.5M
- Share buybacks88¢$11.3M
Out of $1.8M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.3
Financial statements
Every line of the income statement as filed: the last 2 fiscal years (annual) or 8 quarters (quarterly), latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total revenues | $54.9M | $52.2M |
| Total cost of revenues | $11.2M | $11.5M |
| Selling and marketing expenses | $13.3M | $11.0M |
| Depreciation and amortization | $1.6M | $1.4M |
| General and administrative expenses | $29.6M | $30.1M |
| Total selling, general and administrative expenses | $44.6M | $42.5M |
| Net loss on disposition or impairment | $7.9K | $66.0K |
| Loss from continuing operations | -$913.4K | -$1.9M |
| Other income, net | $683.9K | $280.3K |
| Loss from continuing operations before income tax expense | -$229.5K | -$1.6M |
| Income tax expense | $38.7K | $5.6K |
| Net loss from continuing operations | -$268.2K | -$1.6M |
| Income (loss) from discontinued operations before income tax expense | $3.2M | -$4.0M |
| Income tax expense from discontinued operations | $25.2K | $210.3K |
| Net income (loss) from discontinued operations | $3.2M | -$4.2M |
| Net income (loss) | $2.9M | -$5.8M |
| Basic (in dollars per share) | -$0 | -$0 |
| Diluted (in dollars per share) | -$0 | -$0 |
| Basic (in dollars per share) | $0 | -$0 |
| Diluted (in dollars per share) | $0 | -$0 |
| Net income (loss) per common share, basic (in dollars per share) | $0.19 | -$0.39 |
| Net income (loss) per common share, diluted (in dollars per share) | $0.19 | -$0.38 |
| Basic weighted average shares outstanding (in shares) | 15.1M shares | 14.9M shares |
| Diluted weighted average shares outstanding (in shares) | 15.2M shares | 15.1M shares |
| Period ending | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | $15.2M | $13.4M | $13.3M | $13.1M | $14.7M | $12.7M | $12.6M | $12.2M |
| Total cost of revenues | $2.8M | $2.7M | $2.8M | $3.0M | $3.2M | $2.8M | $2.8M | $2.7M |
| Selling and marketing expenses | $3.5M | $2.8M | $3.5M | $3.5M | $2.8M | $2.5M | $3.4M | $2.2M |
| Depreciation and amortization | $433.2K | $446.7K | $402.3K | $361.9K | $353.5K | $345.8K | $342.5K | $329.6K |
| General and administrative expenses | $7.7M | $7.3M | $7.7M | $6.9M | $7.5M | $7.5M | $7.8M | $7.3M |
| Total selling, general and administrative expenses | $11.6M | $10.6M | $11.6M | $10.8M | $10.7M | $10.3M | $11.6M | $9.9M |
| Net loss on disposition or impairment | $1.5K | $0 | $4.4K | $2.0K | $61.5K | $3.6K | $662 | $275 |
| Loss from continuing operations | $742.4K | $160.9K | -$1.1M | -$678.5K | $809.7K | -$492.8K | -$1.8M | -$426.6K |
| Other income, net | $198.2K | $139.8K | $159.9K | $185.9K | $79.7K | $83.8K | $80.5K | $36.3K |
| Loss from continuing operations before income tax expense | $940.6K | $300.7K | -$978.2K | -$492.6K | $889.4K | -$409.0K | -$1.7M | -$390.3K |
| Income tax expense | $3.5K | $10.3K | $11.4K | $13.4K | -$19.5K | $5.4K | $11.2K | $8.6K |
| Net loss from continuing operations | $937.1K | $290.4K | -$989.6K | -$506.0K | $909.0K | -$414.4K | -$1.7M | -$398.9K |
| Income (loss) from discontinued operations before income tax expense | -$224.1K | $664.3K | $1.2M | $1.6M | -$1.1M | -$2.7M | -$1.7M | $1.5M |
| Income tax expense from discontinued operations | -$278.0K | $99.6K | $100.2K | $103.4K | -$184.4K | $57.2K | $167.2K | $170.3K |
| Net income (loss) from discontinued operations | $54.0K | $564.6K | $1.1M | $1.5M | -$891.3K | -$2.8M | -$1.9M | $1.3M |
| Net income (loss) | $991.1K | $855.0K | $93.4K | $967.8K | $17.7K | -$3.2M | -$3.6M | $947.0K |
| Basic (in dollars per share) | $0 | $0 | -$0 | -$0 | $0 | -$0 | -$0 | -$0 |
| Diluted (in dollars per share) | $0 | $0 | -$0 | -$0 | $0 | -$0 | -$0 | -$0 |
| Basic (in dollars per share) | $0 | $0 | $0 | $0 | -$0 | -$0 | -$0 | $0 |
| Diluted (in dollars per share) | $0 | $0 | $0 | $0 | -$0 | -$0 | -$0 | $0 |
| Net income (loss) per common share, basic (in dollars per share) | $0.07 | $0.06 | $0.01 | $0.06 | $0.00 | -$0.21 | -$0.24 | $0.06 |
| Net income (loss) per common share, diluted (in dollars per share) | $0.07 | $0.06 | $0.01 | $0.06 | $0.00 | -$0.21 | -$0.24 | $0.06 |
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.3
| Period ending | 2025-12-31 | 2025-05-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $23.6M | $25.1M | ||
| Restricted cash | $700.1K | $945.1K | ||
| Accounts receivable, net | $2.8M | $2.6M | $2.6M | |
| Deferred franchise and regional development costs, current portion | $945.9K | $1.1M | ||
| Prepaid expenses and other current assets | $1.7M | $1.8M | ||
| Discontinued operations current assets ($1.0 million and $1.1 million attributable to VIEs, respectively) | $22.2M | $43.2M | ||
| Total current assets | $52.1M | $74.6M | ||
| Property and equipment, net | $3.2M | $3.2M | ||
| Operating lease right-of-use asset | $1.6M | $555.5K | ||
| Deferred franchise and regional development costs, net of current portion | $3.8M | $4.5M | ||
| Deposits and other assets | $319.5K | $300.8K | ||
| Total assets | $61.0M | $83.2M | ||
| Accounts payable | $1.6M | $1.8M | ||
| Accrued expenses | $1.5M | $1.5M | ||
| Co-op funds liability | $700.1K | $945.1K | ||
| Payroll liabilities | $4.1M | $3.6M | ||
| Operating lease liability, current portion | $194.2K | $483.3K | ||
| Deferred franchise fee revenue, current portion | $2.5M | $2.5M | ||
| Upfront regional developer fees, current portion | $277.4K | $288.1K | ||
| Other current liabilities | $611.2K | $603.2K | ||
| Discontinued operations current liabilities ($6.1 million and $7.1 million attributable to VIEs, respectively) | $21.4M | $37.4M | ||
| Total current liabilities | $32.8M | $49.0M | ||
| Operating lease liability, net of current portion | $1.8M | $311.7K | ||
| Deferred franchise fee revenue, net of current portion | $10.9M | $12.5M | ||
| Upfront regional developer fees, net of current portion | $355.6K | $672.3K | ||
| Total liabilities | $45.9M | $62.5M | ||
| Series A preferred stock, $0.001 par value; 50,000 shares authorized, zero issued and outstanding, respectively | $0 | $0 | ||
| Common stock, $0.001 par value; 20,000,000 shares authorized, 15,471,715 shares issued and 14,142,626 shares outstanding and 15,192,893 shares issued and 15,159,878 shares outstanding, respectively | $15.5K | $15.2K | ||
| Additional paid-in capital | $52.0M | $49.2M | ||
| Treasury stock 1,329,089 shares and 33,015 shares, at cost, respectively | -$12.2M | -$870.1K | ||
| Accumulated deficit | -$24.8M | -$27.7M | ||
| Total The Joint Corp. stockholders equity | $15.1M | $20.7M | ||
| Non-controlling Interest | $25.0K | $25.0K | ||
| Total equity | $15.1M | $20.7M | $24.8M | |
| Total liabilities and stockholders equity | $61.0M | $83.2M | ||
| Series A preferred stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Series A preferred stock, shares authorized (in shares) | 50.0K shares | 50.0K shares | ||
| Series A preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Series A preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | $0.00 | |
| Common stock, shares authorized (in shares) | 20.0M shares | 20.0M shares | ||
| Common stock, shares issued (in shares) | 15.5M shares | 15.2M shares | ||
| Common stock, shares outstanding (in shares) | 14.1M shares | 15.2M shares | ||
| Treasury stock, shares (in shares) | 1.3M shares | 33.0K shares |
| Period ending | 2025-12-31 | 2025-05-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $23.6M | $25.1M | ||
| Restricted cash | $700.1K | $945.1K | ||
| Accounts receivable, net | $2.8M | $2.6M | $2.6M | |
| Deferred franchise and regional development costs, current portion | $945.9K | $1.1M | ||
| Prepaid expenses and other current assets | $1.7M | $1.8M | ||
| Discontinued operations current assets ($1.0 million and $1.1 million attributable to VIEs, respectively) | $22.2M | $43.2M | ||
| Total current assets | $52.1M | $74.6M | ||
| Property and equipment, net | $3.2M | $3.2M | ||
| Operating lease right-of-use asset | $1.6M | $555.5K | ||
| Deferred franchise and regional development costs, net of current portion | $3.8M | $4.5M | ||
| Deposits and other assets | $319.5K | $300.8K | ||
| Total assets | $61.0M | $83.2M | ||
| Accounts payable | $1.6M | $1.8M | ||
| Accrued expenses | $1.5M | $1.5M | ||
| Co-op funds liability | $700.1K | $945.1K | ||
| Payroll liabilities | $4.1M | $3.6M | ||
| Operating lease liability, current portion | $194.2K | $483.3K | ||
| Deferred franchise fee revenue, current portion | $2.5M | $2.5M | ||
| Upfront regional developer fees, current portion | $277.4K | $288.1K | ||
| Other current liabilities | $611.2K | $603.2K | ||
| Discontinued operations current liabilities ($6.1 million and $7.1 million attributable to VIEs, respectively) | $21.4M | $37.4M | ||
| Total current liabilities | $32.8M | $49.0M | ||
| Operating lease liability, net of current portion | $1.8M | $311.7K | ||
| Deferred franchise fee revenue, net of current portion | $10.9M | $12.5M | ||
| Upfront regional developer fees, net of current portion | $355.6K | $672.3K | ||
| Total liabilities | $45.9M | $62.5M | ||
| Series A preferred stock, $0.001 par value; 50,000 shares authorized, zero issued and outstanding, respectively | $0 | $0 | ||
| Common stock, $0.001 par value; 20,000,000 shares authorized, 15,471,715 shares issued and 14,142,626 shares outstanding and 15,192,893 shares issued and 15,159,878 shares outstanding, respectively | $15.5K | $15.2K | ||
| Additional paid-in capital | $52.0M | $49.2M | ||
| Treasury stock 1,329,089 shares and 33,015 shares, at cost, respectively | -$12.2M | -$870.1K | ||
| Accumulated deficit | -$24.8M | -$27.7M | ||
| Total The Joint Corp. stockholders equity | $15.1M | $20.7M | ||
| Non-controlling Interest | $25.0K | $25.0K | ||
| Total equity | $15.1M | $20.7M | $24.8M | |
| Total liabilities and stockholders equity | $61.0M | $83.2M | ||
| Series A preferred stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Series A preferred stock, shares authorized (in shares) | 50.0K shares | 50.0K shares | ||
| Series A preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Series A preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | $0.00 | |
| Common stock, shares authorized (in shares) | 20.0M shares | 20.0M shares | ||
| Common stock, shares issued (in shares) | 15.5M shares | 15.2M shares | ||
| Common stock, shares outstanding (in shares) | 14.1M shares | 15.2M shares | ||
| Treasury stock, shares (in shares) | 1.3M shares | 33.0K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income (loss) | $2.9M | -$5.8M |
| Depreciation and amortization | $1.7M | $4.7M |
| Net loss on disposition or impairment | $5.4M | $7.8M |
| Net franchise fees recognized upon termination of franchise agreements | -$347.1K | -$239.3K |
| Deferred income taxes | $93.1K | -$55.6K |
| Provision for credit losses | $286.2K | $220.9K |
| Stock-based compensation expense | $1.3M | $1.7M |
| Accounts receivable | $1.5M | -$1.6M |
| Prepaid expenses and other current assets | -$35.4K | $101.2K |
| Deferred franchise costs | $547.2K | $499.3K |
| Deposits and other assets | -$5.3K | $8.8K |
| Accounts payable | -$391.1K | $68.3K |
| Accrued expenses | -$3.0M | $4.6M |
| Payroll liabilities | -$839.9K | $2.4M |
| Operating leases | -$5.1M | -$3.8M |
| Deferred revenue | -$1.4M | -$597.5K |
| Upfront regional developer fees | -$285.4K | -$421.2K |
| Other liabilities | -$543.7K | -$121.4K |
| Net cash provided by operating activities | $1.8M | $9.4M |
| Proceeds from sale of clinics | $7.8M | $554.1K |
| Purchase of property and equipment | -$1.5M | -$1.2M |
| Net cash provided by (used in) investing activities | $6.3M | -$631.5K |
| Payments of finance lease obligations | -$4.4K | -$25.5K |
| Purchases of treasury stock under employee stock plans | -$8.4K | -$9.6K |
| Purchases of common stock under stock repurchase programs | -$11.3M | $0 |
| Proceeds from exercise of stock options | $1.5M | $33.7K |
| Repayment of Debt under the Credit Agreement | $0 | -$2.0M |
| Net cash used in financing activities | -$9.8M | -$2.0M |
| (Decrease) increase in cash, cash equivalents and restricted cash | -$1.7M | $6.8M |
| Interest | $50.7K | $69.4K |
| Income taxes | $626.8K | $610.5K |
| Unpaid purchases of property and equipment | $245.2K | $124.7K |
| Stock option exercise receivable | $0 | $896.8K |
No quarter-by-quarter statement was filed.
Leadership
Who has led JOINT Corp, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
201520202025
- Chief executive officerPeter D. Holt Jul 13, 2016 to May 24, 202411
- Chief executive officerJohn B. Richards Nov 10, 2014 to Mar 28, 201612
- PresidentPeter D. Holt May 11, 2017 to May 24, 202413
- PresidentDavid M. Orwasher Nov 10, 2014 to Nov 10, 201414
- Chief financial officerJake Singleton Nov 8, 2018 to now15
- Chief financial officerJohn P. Meloun Nov 17, 2016 to Jul 2, 201816
- Chief financial officerFrancis T. Joyce Dec 22, 2014 to Mar 22, 201617
- Chief operating officerPeter D. Holt May 3, 2016 to May 4, 201618
- Chief operating officerDavid M. Orwasher Nov 10, 2014 to Nov 10, 201414
Board members and other officers (21)
- OfficerSanjiv Kumar Razdan Oct 16, 2024 to now19
- Chief Dev. & Strategy OfficerDavid M. Orwasher Mar 15, 2016 to Sep 26, 201620
- Chief Marketing OfficerCatherine B. Hall Nov 10, 2014 to Nov 10, 201421
- Board memberMilind Pant Jun 3, 2026 to now22
- Board memberSandra R. Karrmann Jun 5, 2025 to now23
- Board memberChristopher M. Grandpre Jul 23, 2025 to now24
- Board memberSanjiv Kumar Razdan Oct 16, 2024 to now19
- Board memberGlenn J. Krevlin Jun 4, 2019 to May 24, 202425
- Board memberAbe Hong Jun 5, 2018 to now26
- Board memberMatthew E. Rubel Jun 6, 2017 to now27
- Board memberSuzanne M. Decker Jun 12, 2017 to now28
- Board memberPeter D. Holt Aug 30, 2016 to May 24, 202429
- Board memberBret Sanders Apr 22, 2015 to Jun 6, 201730
- Board memberJames H. Amos Jr. Sep 23, 2015 to May 31, 202231
- Board memberRichard A. Kerley Sep 23, 2015 to Jun 5, 201832
- Board memberCraig Colmar Nov 10, 2014 to May 10, 201633
- Board memberJohn B. Richards Nov 10, 2014 to Mar 28, 201612
- Board memberJohn Leonesio Nov 10, 2014 to Feb 3, 201634
- Board memberRonald Davella V. Nov 10, 2014 to now35
- Board memberSteve Colmar Nov 10, 2014 to May 10, 201636
- Board memberWilliam R. Fields Nov 10, 2014 to May 10, 201637
Timeline
Filings
221 filings to the SEC since October 2021: 7 annual reports, 17 quarterly reports, 52 major events, 87 insider forms, 39 large holders, 19 other. The latest 20:
- Oct 1, 20268-K EDGAR
- Aug 7, 202610-Q EDGAR
- Aug 6, 20268-K EDGAR
- Jul 28, 2026SCHEDULE 13G/A EDGAR
- Jun 12, 20264 EDGAR
- Jun 3, 20264 EDGAR
- Jun 3, 20263 EDGAR
- May 22, 20264 EDGAR
- May 22, 20264 EDGAR
- May 22, 20264 EDGAR
- May 22, 20264 EDGAR
- May 21, 20268-K EDGAR
- May 15, 2026SCHEDULE 13G/A EDGAR
- May 14, 20264 PRIMARY DOCUMENT EDGAR
- May 8, 202610-Q EDGAR
- May 7, 20268-K EDGAR
- May 1, 20268-K EDGAR
- Apr 24, 20268-K EDGAR
- Apr 23, 2026SCHEDULE 13G/A EDGAR
- Apr 23, 20264 PRIMARY DOCUMENT EDGAR
The 221 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 39 such filings since October 2021, the latest 10:
- Jul 28, 2026SCHEDULE 13G/A
- May 15, 2026SCHEDULE 13G/A
- Apr 23, 2026SCHEDULE 13G/A
- Mar 27, 2026SCHEDULE 13G/A
- Mar 16, 2026SCHEDULE 13D/A
- Jan 8, 2026SCHEDULE 13G
- Jan 7, 2026SCHEDULE 13D/A
- Nov 13, 2025SCHEDULE 13G/A
- Aug 21, 2025SCHEDULE 13G/A
- Jul 10, 2025SCHEDULE 13G
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 84. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARJOINT Corp filings on SEC EDGAR
- 2SEC EDGARJOINT Corp filings on SEC EDGAR
- 3SEC EDGARJOINT Corp 10-K for fiscal 2025
- 4SEC EDGARJOINT Corp 10-K for fiscal 2019
- 5SEC EDGARJOINT Corp 10-K for fiscal 2020
- 6SEC EDGARJOINT Corp 10-K for fiscal 2021
- 7SEC EDGARJOINT Corp 10-K for fiscal 2022
- 8SEC EDGARJOINT Corp 10-K for fiscal 2022
- 9SEC EDGARJOINT Corp 10-Q for fiscal 2026
- 10SEC EDGARJOINT Corp 10-Q for fiscal 2026
- 11
- 12
- 13SEC EDGARPeter D. Holt, President
- 14SEC EDGARDavid M. Orwasher, President
- 15
- 16
- 17
- 18
- 19SEC EDGARSanjiv Kumar Razdan, Officer
- 20
- 21
- 22SEC EDGARMilind Pant, Board member
- 23SEC EDGARSandra R. Karrmann, Board member
- 24
- 25SEC EDGARGlenn J. Krevlin, Board member
- 26SEC EDGARAbe Hong, Board member
- 27SEC EDGARMatthew E. Rubel, Board member
- 28SEC EDGARSuzanne M. Decker, Board member
- 29SEC EDGARPeter D. Holt, Board member
- 30SEC EDGARBret Sanders, Board member
- 31SEC EDGARJames H. Amos Jr., Board member
- 32SEC EDGARRichard A. Kerley, Board member
- 33SEC EDGARCraig Colmar, Board member
- 34SEC EDGARJohn Leonesio, Board member
- 35SEC EDGARRonald Davella V., Board member
- 36SEC EDGARSteve Colmar, Board member
- 37SEC EDGARWilliam R. Fields, Board member